Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 7.01, 9.01 · 8-K

Tactile Systems Technology, Inc.

TCMDNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On March 4, 2026, the board of directors of Tactile Systems Technology, Inc. (the “Company”) elected Andrea A. Pearson to serve as a member of the board and fixed the size of the board at nine directors, all effective as of March 9, 2026. Ms.…

Filed Mar 9, 2026Accepted Mar 9, 2026, 4:06 AM EDTCIK 1027838Accession 0001104659-26-024981
Share

Company context

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic respiratory conditions by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Current securities

Recent company filings

  1. 10-Q/A filingNov 3, 2026
  2. 10-Q/A filingNov 3, 2026
  3. 10-Q filingNov 2, 2026
  4. Results of Operations and Financial ConditionNov 2, 2026
  5. 144 filingAug 20, 2026

Registered securities in this filing

TACTILE SYSTEMS TECHNOLOGY INC · 8-K · Filed 2026-03-09

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, Par Value $0.001 Per Share

Symbol
TCMD
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-03-04

Dimensions: Not supplied

Accession 000110465926024981 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On March 4, 2026, the board of directors of Tactile Systems Technology, Inc. (the “Company”) elected Andrea A. Pearson to serve as a member of the board and fixed the size of the board at nine directors, all effective as of March 9, 2026. Ms. Pearson was also appointed to serve as a member of the Compliance and Reimbursement Committee and of the Nominating and Corporate Governance Committee of the board. Since 2024, Ms. Pearson has served as a strategic advisor and fractional Chief Marketing Officer/Chief Growth Officer for human and animal healthcare companies, including her role as Growth Advisor and Chief Marketing Officer at Harbor Health, a healthcare organization that integrates clinical care with health insurance coverage, from April 2024 to January 2026. Prior to that, Ms. Pearson served as Chief Growth Officer at DispatchHealth, a leader in at-home, hospital-level care, from October 2019 to March 2024 and as Chief Marketing Officer at DispatchHealth from January 2018 to October 2019. Previously, Ms. Pearson served in executive roles at Healthgrades from 2008 to 2017, including Executive Vice President and Chief Marketing Officer and Executive Vice President and General Manager of Consumer Products. Ms. Pearson served as General Manager of MapQuest.com from 2002 to 2007. For her service on the board, Ms. Pearson will be compensated in accordance with the Company’s non-employee director compensation policy. Ms. Pearson will be granted restricted stock units (“RSUs”) with a value of a pro rata portion of $155,000, such pro rata portion based on the number of days Ms. Pearson will serve until the next annual meeting of stockholders as compared to the number of days between that annual meeting and the immediately preceding annual meeting of stockholders, calculated by dividing the pro rata portion of $155,000 by the closing sale price per share of the Company’s common stock on the Nasdaq Global Market on the date of grant. These RSUs will be granted on March 9, 2026, and will vest in a single installment on the date of the Company’s 2026 annual meeting of stockholders, subject to the condition that Ms. Pearson remain a director as of that date. In addition, Ms. Pearson will receive an annual cash retainer of $50,000 per year for her service on the board, a cash retainer of $5,000 per year for her service as a member of the Compliance and Reimbursement Committee, and a cash retainer of $5,000 per year for her service as a member of the Nominating and Corporate Governance Committee, each prorated for her first year of service. Non-employee directors may elect to receive between 10% and 100% of their aggregate annual cash retainers in the form of RSUs, with the number of RSUs calculated by dividing the amount of the retainer payable on a certain date by the closing sale price per share of the Company’s common stock on the date of grant. The Company also reimburses its directors for their reasonable out-of-pocket expenses incurred in connection with attending board and committee meetings.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure On March 9, 2026, the Company issued a press release in connection with Ms. Pearson’s appointment to the board. Attached hereto as Exhibit 99.1 is a copy of the press release. In accordance with General Instruction B.2 of Form 8-K, the information in this report under this heading, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934. Item 9.01. Financial Statements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit Description No. ──────────────────────────────────────────────────────────────────────────────────────────── 99.1 Press Release dated March 9, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Filed exhibits (1)
EX-99.1 (by filename) tm268267d1_ex99-1.htm

EX-99.1 2 tm268267d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson MINNEAPOLIS, MN, March 9, 2026 - Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company’s Board of Directors (“Board”) and as a member of the Compliance & Reimbursement and Nominating & Corporate Governance Committees, effective March 9, 2026. Ms. Pearson is an accomplished senior executive and growth strategist with deep expertise in scaling healthcare organizations. Her extensive experience spans more than 25 years and includes exposure to product development, customer acquisition, branding, marketing communications, and public relations. Most recently, she served as Growth Advisor and Chief Marketing Officer at Harbor Health, a healthcare organization that integrates clinical care with health insurance coverage. Previously, she was Chief Growth Officer, and, before that, Chief Marketing Officer at DispatchHealth, a leader in at-home, hospital-level care, wher…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.